GJB2 and pancreatic neoplasm: GJB2 and ERO1LB levels were shown to have prognostic significance and therapeutic strategies targeting GJB2 and facilitating ERO1LB expression may deserve evaluation to improve prognosis of pancreatic cancer patients.